1-20 of 20
Sort by
News

November 2022 Data Stream

Published: 2022
Abstract
November 2022
View News titled, November 2022 Data Stream
News

Guided By the Lines: The ASH Clinical Practice Guidelines From A to Z

Published: 2022
Abstract
November 2022
View News titled, Guided By the Lines: The ASH Clinical Practice Guidelines From A to Z
News

AML Framework IDs 16 Subgroups, 3 Risk Strata

Leah Lawrence
Published: 2022
Abstract
November 2022
View News titled, AML Framework IDs 16 Subgroups, 3 Risk Strata
News

Caplacizumab Reduces Exacerbations and Refractoriness in Real-World iTTP

Brandon May
Published: 2022
Abstract
November 2022
View News titled, Caplacizumab Reduces Exacerbations and Refractoriness in Real-World iTTP
News

EPd Triplet Therapy Boosts Survival in R/R MM Vs. Pd

Brandon May
Published: 2022
Abstract
November 2022
View News titled, EPd Triplet Therapy Boosts Survival in R/R MM Vs. Pd
News

Long-Term Dabigatran Offers Anticoagulation Alternative in High-Risk Pediatric Thrombophilia

Leah Lawrence
Published: 2022
Abstract
November 2022
View News titled, Long-Term Dabigatran Offers Anticoagulation Alternative in High-Risk Pediatric Thrombophilia
News

Vemurafenib Retreatment Deemed Effective in R/R Hairy Cell Leukemia

Brandon May
Published: 2022
Abstract
November 2022
View News titled, Vemurafenib Retreatment Deemed Effective in R/R Hairy Cell Leukemia
News

Pathogenic Germline Variants Seen in Older Patients With MDS More Frequently Than Expected

Thomas R. Collins
Published: 2022
Abstract
November 2022
View News titled, Pathogenic Germline Variants Seen in Older Patients With MDS More Frequently Than Expected
News

Third COVID-19 Vaccine Dose Recommended for Patients With Hematologic Cancers

Published: 2022
Abstract
November 2022
View News titled, Third COVID-19 Vaccine Dose Recommended for Patients With Hematologic Cancers
News

Omidubicel Granted Priority Review for Hematologic Malignancies

Published: 2022
Abstract
November 2022
View News titled, Omidubicel Granted Priority Review for Hematologic Malignancies
News

Alcabrutinib Tablet Formulation Approved Across All Indications

Published: 2022
Abstract
November 2022
View News titled, Alcabrutinib Tablet Formulation Approved Across All Indications
News

Approval for Prophylactic Hemophilia B Treatment Expanded

Published: 2022
Abstract
November 2022
View News titled, Approval for Prophylactic Hemophilia B Treatment Expanded
News

Higher CAR T Doses May Improve Survival Outcomes

Published: 2022
Abstract
November 2022
View News titled, Higher CAR T Doses May Improve Survival Outcomes
News

You Make the Call: What would you advise for a male patient with SCD receiving HU who is concerned about teratogenicity?

Published: 2022
Abstract
November 2022
View News titled, You Make the Call: What would you advise for a male patient with SCD receiving HU who is concerned about teratogenicity?
News

What would you advise for a male patient with SCD receiving HU who is concerned about teratogenicity?

Published: 2022
Abstract
November 2022
View News titled, What would you advise for a male patient with SCD receiving HU who is concerned about teratogenicity?
News

rFVIIIFc and rFIXFc Support Perioperative Hemostasis Management in Patients With Hemophilia

Brandon May
Published: 2022
Abstract
November 2022
View News titled, rFVIIIFc and rFIXFc Support Perioperative Hemostasis Management in Patients With Hemophilia
News

When the Hematologist Is the Patient

Published: 2022
Abstract
November 2022
View News titled, When the Hematologist Is the Patient
News

Hydroxyurea Use Does Not Increase Risk of Secondary Malignancies with MPNs

Brandon May
Published: 2022
Abstract
November 2022
View News titled, Hydroxyurea Use Does Not Increase Risk of Secondary Malignancies with MPNs
News

Pregnancy Does Not Increase Risk of Severe Bleeding in ITP

Leah Lawrence
Published: 2022
Abstract
November 2022
View News titled, Pregnancy Does Not Increase Risk of Severe Bleeding in ITP
News

You Really Got a Hold on Me

Lara C. Pullen, PhD
Published: 2022
Abstract
November 2022 Taking a close look at clinical holds reveals them to be an integral safety mechanism in the investigation and approval of important hematologic treatments.
View News titled, You Really Got a Hold on Me